[go: up one dir, main page]

DK0749481T3 - Humaniserede monoklonale antistoffer mod human interleukin-4 - Google Patents

Humaniserede monoklonale antistoffer mod human interleukin-4

Info

Publication number
DK0749481T3
DK0749481T3 DK95912620T DK95912620T DK0749481T3 DK 0749481 T3 DK0749481 T3 DK 0749481T3 DK 95912620 T DK95912620 T DK 95912620T DK 95912620 T DK95912620 T DK 95912620T DK 0749481 T3 DK0749481 T3 DK 0749481T3
Authority
DK
Denmark
Prior art keywords
monoclonal antibodies
human
humanized monoclonal
human interleukin
antibodies
Prior art date
Application number
DK95912620T
Other languages
English (en)
Inventor
Stephen Tindall
Barbara Dalie
Kenneth Miller
Nicholas Murgolo
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK0749481T3 publication Critical patent/DK0749481T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/247—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK95912620T 1994-03-10 1995-03-08 Humaniserede monoklonale antistoffer mod human interleukin-4 DK0749481T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/208,886 US5597710A (en) 1994-03-10 1994-03-10 Humanized monoclonal antibodies against human interleukin-4
PCT/US1995/002400 WO1995024481A2 (en) 1994-03-10 1995-03-08 Humanized monoclonal antibodies against human interleukin-4

Publications (1)

Publication Number Publication Date
DK0749481T3 true DK0749481T3 (da) 1999-06-14

Family

ID=22776442

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95912620T DK0749481T3 (da) 1994-03-10 1995-03-08 Humaniserede monoklonale antistoffer mod human interleukin-4

Country Status (10)

Country Link
US (1) US5597710A (da)
EP (1) EP0749481B1 (da)
JP (1) JPH09510095A (da)
AT (1) ATE171473T1 (da)
AU (1) AU1971295A (da)
CA (1) CA2185112C (da)
DE (1) DE69504959T2 (da)
DK (1) DK0749481T3 (da)
ES (1) ES2121358T3 (da)
WO (1) WO1995024481A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928904A (en) * 1993-09-07 1999-07-27 Smithkline Beecham Corporation DNA encoding recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US20020193575A1 (en) * 1993-09-07 2002-12-19 Smithkline Beecham P.L.C. Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US5914110A (en) * 1993-09-07 1999-06-22 Smithkline Beecham Corporation Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
JP2001523958A (ja) 1997-03-21 2001-11-27 ブライハム アンド ウィミンズ ホスピタル，インコーポレイテッド 免疫療法のｃｔｌａ−４結合ペプチド
US5994511A (en) * 1997-07-02 1999-11-30 Genentech, Inc. Anti-IgE antibodies and methods of improving polypeptides
US6172213B1 (en) 1997-07-02 2001-01-09 Genentech, Inc. Anti-IgE antibodies and method of improving polypeptides
US7083950B2 (en) * 1998-09-25 2006-08-01 Regeneron Pharmaceuticals, Inc. High affinity fusion proteins and therapeutic and diagnostic methods for use
US7994278B1 (en) * 1999-08-06 2011-08-09 Nobel Biosciences Llc Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
JP2001275677A (ja) * 2000-03-30 2001-10-09 Canon Inc 核酸断片プライマーまたはプローブ、およびこれを用いたポリヒドロキシアルカノエート合成微生物の検出方法
US20070104710A1 (en) * 2002-06-28 2007-05-10 Domants Limited Ligand that has binding specificity for IL-4 and/or IL-13
US20110223168A1 (en) * 2002-12-27 2011-09-15 Greg Winter Ligand that has binding specificity for il-4 and/or il-13
AR050044A1 (es) * 2004-08-03 2006-09-20 Novartis Ag Anticuerpo especifico de il-4
AR060017A1 (es) 2006-01-13 2008-05-21 Novartis Ag Composiciones y metodos de uso para anticuerpos de dickkopf -1
EP2050764A1 (en) 2007-10-15 2009-04-22 sanofi-aventis Novel polyvalent bispecific antibody format and uses thereof
AR095774A1 (es) * 2013-04-05 2015-11-11 Genentech Inc Anticuerpos anti-il-4 y anticuerpos biespecíficos y sus usos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0088994B1 (en) * 1982-03-15 1991-06-19 Schering Corporation Hybrid dna, binding composition prepared thereby and processes therefor
US4731237A (en) * 1983-11-07 1988-03-15 The Wistar Institute Immune response to virus induced by anti-idiotype antibodies
US5041381A (en) * 1986-07-03 1991-08-20 Schering Corporation Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
GB8607679D0 (en) * 1986-03-27 1986-04-30 Winter G P Recombinant dna product
ATE93144T1 (de) * 1988-02-02 1993-09-15 Schering Biotech Corp Methode zur verminderung der immunglobulin-ereaktion.
JPH0730116B2 (ja) * 1989-12-20 1995-04-05 シェリング・コーポレーション ヒトインターロイキン―４の抗体アンタゴニスト
GB8928874D0 (en) * 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
CA2041271A1 (en) * 1990-04-30 1991-10-31 Bradford A. Jameson Peptide analogs to proteins of the immunoglobin superfamily
ES2121078T3 (es) * 1992-02-19 1998-11-16 Schering Corp Clonacion y expresion de anticuerpos monoclonales humanizados contra interleuquina-4 humana.

Also Published As

Publication number Publication date
ES2121358T3 (es) 1998-11-16
AU1971295A (en) 1995-09-25
DE69504959D1 (de) 1998-10-29
WO1995024481A3 (en) 1995-10-19
WO1995024481A2 (en) 1995-09-14
EP0749481B1 (en) 1998-09-23
DE69504959T2 (de) 1999-02-18
EP0749481A1 (en) 1996-12-27
CA2185112A1 (en) 1995-09-14
ATE171473T1 (de) 1998-10-15
CA2185112C (en) 2000-10-31
JPH09510095A (ja) 1997-10-14
US5597710A (en) 1997-01-28

Similar Documents

Publication Publication Date Title
ATE171472T1 (de) Klonierung und expression von humanisierten monoklonalen antikörpern gegen menschliches interleukin-4
DK101890A (da) Monoklonale antistoffer mod human interleukin-4 og hybridomaer, der producerer saadanne
DK0749481T3 (da) Humaniserede monoklonale antistoffer mod human interleukin-4
ATE177754T1 (de) Fragmente von prion proteinen.
ATE303161T1 (de) Humanisierung von anti-carcinoembryonalen antigen anti-idiotypischen antikörper und dessen verwendung als tumorvakzin und zur markierung
DK0980429T3 (da) Human Toll-lignende receptorproteiner, beslægtede reagenser og fremgangsmåder
ATE249476T1 (de) Cyclin d1 und seine cdna
FR08C0006I1 (fr) Anticorps monoclonaux humains contre le recepteur du facteur de croissance epidermique
ES2133813T3 (es) Cadenas de lamininas: diagnostico y uso terapeutico.
ATE132197T1 (de) Monoklonale antikörper
DE69531958D1 (de) (1-3)-beta-d-glukon-bindungsprotein, antikörper der dieses protein erkennt undverwendung des proteins und antikörper
IT1207589B (it) Composizione di anticorpi monoclonali umani cross-protettivi.
DE3689948D1 (de) Monoklonale antikörper und testverfahren.
ATE191568T1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
IT1231727B (it) Peptidi utili per la determinazione e la purificazione di anticorpi anti gamma interferone.
DE69728897D1 (de) Saeugetierchemokine
DE3585049D1 (de) Monoklonale antikoerper.
DE3580482D1 (de) Monoklonale antikoerper und immunisierung damit.
DE68907377D1 (de) Agens und geraet zur bestimmung von antigenen oder antikoerpern.
FI956041A (fi) Kompositiot ja diagnostiset menetelmät, joissa käytetään monoklonaalisia vasta-aineita CD44V6 vastaan
NO20000079D0 (no) Ancrod spesifikke monoklonale antistoff, antistoff- fragmenter, blandinger, derivater og anvendelse derav
IT9006602A0 (it) Test immunoenzimatico per la ricerca e determinazione degli anticorpi anti-ss-dna.
ATE58173T1 (de) Monoklonale antikoerper und immunisierung damit.